Loading...
Strategies for Optimizing the Clinical Impact of Immunotherapeutic Agents Such as Sipuleucel-T in Prostate Cancer
Sipuleucel-T is a therapeutic cancer vaccine that has shown improved survival in men with metastatic castration-resistant prostate cancer. As a first-in-class agent, it has been met with both fanfare and controversy. A broad review of immune-based therapies may reveal the delayed clinical impact of...
Na minha lista:
| Udgivet i: | J Natl Compr Canc Netw |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599514/ https://ncbi.nlm.nih.gov/pubmed/23221788 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|